The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 26, 2022

Filed:

Jan. 14, 2019
Applicants:

Nationwide Children's Hospital, Columbus, OH (US);

Ohio State Innovation Foundation, Columbus, OH (US);

Inventors:

Brian K. Kaspar, Westerville, OH (US);

Arthur Burghes, Columbus, OH (US);

Paul Porensky, Columbus, OH (US);

Assignees:

NATIONWIDE CHILDREN'S HOSPITAL, Columbus, OH (US);

OHIO STATE INNOVATION FOUNDATION, Columbus, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C12N 15/86 (2006.01); C07H 21/04 (2006.01); A61K 38/17 (2006.01); A61K 49/04 (2006.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0075 (2013.01); A61K 38/1709 (2013.01); A61K 48/0008 (2013.01); A61K 49/0438 (2013.01); C07K 14/47 (2013.01); C12N 15/86 (2013.01); A61K 48/00 (2013.01); C07H 21/04 (2013.01); C12N 2750/14143 (2013.01);
Abstract

The present invention relates to Adeno-associated virus type 9 methods and materials useful for intrathecal delivery of polynucleotides. Use of the methods and materials is indicated, for example, for treatment of lower motor neuron diseases such as SMA and ALS as well as Pompe disease and lysosomal storage disorders. It is disclosed that administration of a non-ionic, low-osmolar contrast agent, together with a rAA9 vector for the expression of Survival Motor Neuron protein, improves the survival of SMN mutant mice as compared to the administration of the expression vector alone.


Find Patent Forward Citations

Loading…